Disappointing Topline Results for Clazosentan in Aneurysmal SAH ...Middle East

News by : (Medscape) -
Clazosentan failed to prevent clinical deterioration as a result of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage in the phase 3 REACT trial. Medscape Medical News

Hence then, the article about disappointing topline results for clazosentan in aneurysmal sah was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Disappointing Topline Results for Clazosentan in Aneurysmal SAH )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار